Polaryx Therapeutics, Inc. — All Filings
23 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | ANNUAL REPORT | 0001213900-26-033064 | Mar 24, 2026 | Dec 31, 2025 |
| 4 | — | 0001213900-26-018845 | Feb 20, 2026 | Feb 18, 2026 |
| SCHEDULE 13D | — | 0001213900-26-012759 | Feb 5, 2026 | — |
| 424B4 | PROSPECTUS | 0001213900-26-010761 | Feb 2, 2026 | — |
| EFFECT | — | 9999999995-26-000339 | Jan 29, 2026 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-009664 | Jan 29, 2026 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-009569 | Jan 29, 2026 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-009567 | Jan 29, 2026 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-009566 | Jan 29, 2026 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-009565 | Jan 29, 2026 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-009564 | Jan 29, 2026 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-26-009563 | Jan 29, 2026 | — |
| CERT | — | 0001354457-26-000098 | Jan 28, 2026 | — |
| 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-26-008173 | Jan 27, 2026 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-26-007973 | Jan 27, 2026 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-26-004079 | Jan 14, 2026 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-25-113249 | Nov 21, 2025 | — |
| C-U | — | 0001213900-25-104723 | Oct 31, 2025 | — |
| C-U | — | 0001213900-25-102529 | Oct 27, 2025 | — |
| C/A | — | 0001213900-25-094743 | Oct 1, 2025 | — |
| DRS/A | — | 0001213900-25-089144 | Sep 19, 2025 | — |
| C | — | 0001213900-25-084152 | Sep 3, 2025 | — |
| DRS | — | 0001213900-25-072048 | Aug 5, 2025 | — |